190 related articles for article (PubMed ID: 22173140)
1. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children.
Coles CL; Levens J; Seidman JC; Mkocha H; Munoz B; West S
Pediatr Infect Dis J; 2012 Apr; 31(4):341-6. PubMed ID: 22173140
[TBL] [Abstract][Full Text] [Related]
2. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
[TBL] [Abstract][Full Text] [Related]
3. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
4. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
[TBL] [Abstract][Full Text] [Related]
6. Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children.
Coles CL; Seidman JC; Levens J; Mkocha H; Munoz B; West S
Am J Trop Med Hyg; 2011 Oct; 85(4):691-6. PubMed ID: 21976574
[TBL] [Abstract][Full Text] [Related]
7. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
8. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
[TBL] [Abstract][Full Text] [Related]
9. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
[TBL] [Abstract][Full Text] [Related]
10. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
[TBL] [Abstract][Full Text] [Related]
12. Outcome of azithromycin treatment of active trachoma in Omani school children.
Khandekarf R; Mohammed AJ
East Mediterr Health J; 2003; 9(5-6):1026-33. PubMed ID: 16450533
[TBL] [Abstract][Full Text] [Related]
13. Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settings.
Kigen G; Rotich J; Karimurio J; Rono H
Pan Afr Med J; 2014; 19():256. PubMed ID: 25852799
[TBL] [Abstract][Full Text] [Related]
14. Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania.
Frick KD; Lynch M; West S; Munoz B; Mkocha HA
Bull World Health Organ; 2003; 81(2):101-7. PubMed ID: 12751418
[TBL] [Abstract][Full Text] [Related]
15. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.
Whitty CJ; Glasgow KW; Sadiq ST; Mabey DC; Bailey R
Pediatr Infect Dis J; 1999 Nov; 18(11):955-8. PubMed ID: 10571428
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study.
O'Grady KA; Lee KJ; Carlin JB; Torzillo PJ; Chang AB; Mulholland EK; Lambert SB; Andrews RM
Clin Infect Dis; 2010 Apr; 50(7):970-8. PubMed ID: 20192729
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in subjects hospitalized with acute lower respiratory tract infections.
Sehgal V; Sethi GR; Sachdev HP; Satyanarayana L
Indian Pediatr; 1997 Mar; 34(3):213-9. PubMed ID: 9282488
[TBL] [Abstract][Full Text] [Related]
19. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
[TBL] [Abstract][Full Text] [Related]
20. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
